A genetic testing company whose sales of genetic testing kits were recently halted by the FDA has been hit with a $5 million lawsuit, reports The Huffington Post.
The Google-based company 23andMe was ordered by the Food and Drug Administration on Nov. 27 to stop selling their genetic testing spit-kits, where for $99 the company offers to analyze a costumer’s saliva sample and give back DNA information and propensity for a variety of diseases and conditions. The FDA claims that the company violates U.S. law, as the testing kits have not been given clearance by the federal government to make claims of a medical nature.
A San Diego, Calif. resident has taken it one step further and slammed the company with a $5 million class action lawsuit for its sale of the kit. The lawsuit claims that the kits are meaningless, falsely advertised, unsupported by scientific evidence, and a guise to begin a DNA database. 23andMe declined to comment on the legal proceedings.
Before the legal trouble, 23andMe has been criticized for clearing the path for a “designer baby” market because of a patent is holds to allow recipients of eggs and sperm to asses how their genes will combine with a donor’s genes. The company has since announced that they will not implement the technology in fertility clinics.
We will keep you updated as this story unfolds.
The Parrish Law Firm defective product attorney works with northern Virginia residents who have suffered from defective or falsely-advertised products. Contact us today for a free case consultation, or call us at 703-906-4229.
A representative of the Parrish Law Firm, PLLC researched and wrote this article with Mr. Parrish’s consent. If you have any questions regarding the legal implications of what you have just read, please send us your question by clicking here so we can have our attorney review it.